Optimizing safety surveillance for COVID-19 vaccines

Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to...

Descripción completa

Detalles Bibliográficos
Autor principal: Chandler, Rebecca E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298922/
https://www.ncbi.nlm.nih.gov/pubmed/32555401
http://dx.doi.org/10.1038/s41577-020-0372-8
_version_ 1783547298768224256
author Chandler, Rebecca E.
author_facet Chandler, Rebecca E.
author_sort Chandler, Rebecca E.
collection PubMed
description Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to propel vaccine safety monitoring into the twenty-first century.
format Online
Article
Text
id pubmed-7298922
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72989222020-06-17 Optimizing safety surveillance for COVID-19 vaccines Chandler, Rebecca E. Nat Rev Immunol Comment Evolution of the current infrastructure for surveillance of vaccine safety will be essential to meet our commitments to the public in the deployment of a vaccine (or vaccines) to COVID-19. The incorporation of concepts and tools within the fields of data science and systems immunology can be used to propel vaccine safety monitoring into the twenty-first century. Nature Publishing Group UK 2020-06-17 2020 /pmc/articles/PMC7298922/ /pubmed/32555401 http://dx.doi.org/10.1038/s41577-020-0372-8 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Chandler, Rebecca E.
Optimizing safety surveillance for COVID-19 vaccines
title Optimizing safety surveillance for COVID-19 vaccines
title_full Optimizing safety surveillance for COVID-19 vaccines
title_fullStr Optimizing safety surveillance for COVID-19 vaccines
title_full_unstemmed Optimizing safety surveillance for COVID-19 vaccines
title_short Optimizing safety surveillance for COVID-19 vaccines
title_sort optimizing safety surveillance for covid-19 vaccines
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298922/
https://www.ncbi.nlm.nih.gov/pubmed/32555401
http://dx.doi.org/10.1038/s41577-020-0372-8
work_keys_str_mv AT chandlerrebeccae optimizingsafetysurveillanceforcovid19vaccines

Ejemplares similares